Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Children and Adolescents - a Pilot Randomized Controlled Trial

NCT07772427 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07772427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07772427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Children and Adolescents - a Pilot Randomized Controlled Trial
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
September 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine headache